Bleakley Financial Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.61M | Buy |
80,160
+20,881
| +35% | +$2.24M | 0.22% | 86 |
|
|
2025
Q1 | $5.98M | Buy |
59,279
+6,901
| +13% | +$696K | 0.19% | 104 |
|
|
2024
Q4 | $4.68M | Buy |
52,378
+12,788
| +32% | +$1.14M | 0.14% | 125 |
|
|
2024
Q3 | $3.32M | Sell |
39,590
-245,894
| -86% | -$20.6M | 0.1% | 173 |
|
|
2024
Q2 | $22M | Sell |
285,484
-2,490
| -0.9% | -$192K | 0.63% | 25 |
|
|
2024
Q1 | $19.7M | Buy |
287,974
+16,592
| +6% | +$1.14M | 0.57% | 27 |
|
|
2023
Q4 | $15.7M | Buy |
271,382
+3,010
| +1% | +$174K | 0.5% | 38 |
|
|
2023
Q3 | $14.2M | Buy |
268,372
+6,562
| +3% | +$346K | 0.5% | 37 |
|
|
2023
Q2 | $14.2M | Buy |
261,810
+4,449
| +2% | +$241K | 0.44% | 42 |
|
|
2023
Q1 | $12.9M | Buy |
257,361
+7,461
| +3% | +$373K | 0.43% | 43 |
|
|
2022
Q4 | $11.6M | Buy |
+249,900
| New | +$11.6M | 0.41% | 47 |
|